Video Latest - ecancer

Advances in first line treatment options for MCL patients

Professor Steven Le Gouill and Professor Simon Rule

11 Jun 2016

Targeted genome editing in haematopoeitic stem cells

Prof Luigi Naldini - Universita Vita-Salute San Raffaele, Milan, Italy

11 Jun 2016

A microRNA driver of B-cell leukaemia

Prof Luigi Naldini - Universita Vita-Salute San Raffaele, Milan, Italy

11 Jun 2016

The latest in CLL from EHA 2016

Prof Peter Hillmen, Prof Paolo Ghia, Dr Chris Fox and Dr Constantine Tam

11 Jun 2016

Safety and efficacy of imatinib generics

Prof Tomasz Sacha - Jagiellonian University, Krakow, Poland

11 Jun 2016

Older patients with AML benefit greatly from SGN-CD33 and HMA therapy combo

Dr Amir Fathi, Massachusetts General Hospital, Boston, USA

11 Jun 2016

Meta-analysis of overall survival in multiple myeloma treated with lenalidomide

Dr Philip McCarthy - Roswell Park Cancer Institute, New York, USA

11 Jun 2016

Risk adapted therapy for acute myeloid leukaemia

Prof Jorge Sierra - Hospital de Sant Pau, Barcelona, Spain

11 Jun 2016

Clinical characteristics and prognostic factors of plasmablastic lymphoma patients

Dr Emmanuelle Tchernonog - CHRU Montpellier, Montpellier, France

11 Jun 2016

Blinatumomab improves survival of relapsed B-cell leukaemia

Prof Max Topp - University of Würzburg, Würzburg, Germany

11 Jun 2016

Decoding the risk of thromboembolic events in lymphoma patients

Prof Darko Antic - Clinic For Hematology, Clinical Center Serbia, Belgrade, Serbia

11 Jun 2016

SGN-CD33A combined with HMA therapy produces high remission rates among older patients with AML

Dr Amir Fathi - Massachusetts General Hospital, Boston, USA

11 Jun 2016

Video